Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021
Heather S. Lipkind(Cornell University), Elyse O. Kharbanda(HealthPartners), Darios Getahun(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente), Ousseny Zerbo(Kaiser Permanente), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Jingyi Zhu, Christina M. Ackerman‐Banks(Baylor College of Medicine), Malini B. DeSilva(HealthPartners), Christine K. Olson(National Center for Chronic Disease Prevention and Health Promotion), Candace C. Fuller(Harvard University), Michael M. McNeil(Centers for Disease Control and Prevention), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Eric Weintraub, Thomas G. Boyce(Centers for Disease Control and Prevention), Joshua T.B. Williams(Denver Health Medical Center), Gabriela Vazquez‐Benitez, Kimberly K. Vesco(Kaiser Permanente)
Cited by 207
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602